Thermo Fisher Scientific TMO today announced that it has received approval from the European
Commission (EC) for its pending acquisition of Life Technologies
Corporation LIFE.
To expedite the approval, Thermo Fisher has committed to divest of its
cell culture (sera and media), gene modulation and magnetic beads
businesses. Combined, these businesses had 2012 revenue of approximately
$225 million.
The acquisition remains subject to additional regulatory approvals,
including the U.S. Federal Trade Commission (FTC). Based on its
discussions with the FTC, Thermo Fisher does not believe any additional
divestures will be required in order to receive U.S. approval. The
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in